The correlation between clinicopathological characteristics and HER2 status (low or negative) showed a significant statistical difference (p < 0.0001) in relation to SBR grade, tumor stage, tumor size, and lymph node involvement. The gene discussed is ERBB2; the disease is neoplasm.